CME:NGS-CME Group Inc.

EQUITY | Brokers & Exchanges | Nasdaq Global Select

Last Closing

USD 183.43

Change

0.00 (0.00)%

Market Cap

USD 38.11B

Volume

1.53M

Analyst Target

USD 200.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CME Group Inc through its futures exchanges & clearing houses, serves the risk management & investment needs of customers. It offers products like futures & options, foreign exchange, energy, agricultural commodities, weather derivatives & real estate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-19 )

Largest Industry Peers for Brokers & Exchanges

ETFs Containing CME

GDPY:CA Guardian Directed Premium.. 7.46 % 0.00 %

-0.02 (0%)

CAD 0.05B
GDPY-B:CA Guardian Directed Premium.. 7.46 % 0.00 %

N/A

CAD 0.13B
GDEP:CA Guardian Directed Equity .. 5.04 % 0.00 %

N/A

CAD 0.01B
GDEP-B:CA Guardian Directed Equity .. 5.04 % 0.00 %

N/A

CAD 0.05B
BCDF Listed Funds Trust - Hori.. 4.58 % 0.00 %

+0.16 (+0%)

USD 9.29M
XFNT:XETRA Xtrackers MSCI Fintech In.. 3.63 % 0.00 %

+0.81 (+0%)

USD 7.43M
BAMG 3.43 % 0.00 %

N/A

N/A
XFNT:LSE Xtrackers MSCI Fintech In.. 3.42 % 0.00 %

+1.15 (+0%)

USD 7.43M
XFSN:LSE Xtrackers MSCI Fintech In.. 3.42 % 0.00 %

+0.69 (+0%)

USD 7.43M
TULV:CA TD Q U.S. Low Volatility .. 2.77 % 0.00 %

+0.03 (+0%)

CAD 0.06B
AIVL WisdomTree Trust - Wisdom.. 2.58 % 0.00 %

+0.45 (+0%)

USD 0.36B
MOAT:SW VanEck Morningstar US Sus.. 2.56 % 0.00 %

+0.45 (+0%)

N/A
OWLU:LSE 2.13 % 0.00 %

N/A

N/A
JHDV John Hancock Exchange Tra.. 2.02 % 0.00 %

+0.35 (+0%)

USD 8.22M
CYH Community Health Systems .. 0.00 % 1.49 %

+0.12 (+0%)

USD 0.44B
IAI iShares U.S. Broker-Deale.. 0.00 % 0.42 %

+0.22 (+0%)

USD 0.49B
KOIN Capital Link Global Finte.. 0.00 % 0.65 %

+0.25 (+0%)

USD 0.01B
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

-50.00 (0%)

USD 0.01B
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+1.15 (+0%)

USD 0.01B
MVUS:PA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.01B
SPMV:PA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 7.79M
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.00 %

-1.70 (0%)

N/A
OWLE:F 0.00 % 0.00 %

N/A

N/A
OSX2:XETRA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

+0.30 (+0%)

USD 0.12B
ZFIN:CA 0.00 % 0.00 %

N/A

N/A
OWLE:XETRA 0.00 % 0.00 %

N/A

N/A
OWLU:XETRA 0.00 % 0.00 %

N/A

N/A
DIVS SmartETFs Dividend Builde.. 0.00 % 0.00 %

+0.21 (+0%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Brokers & Exchanges) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.49% 13% F 11% F
Dividend Return N/A N/A N/A N/A F
Total Return -2.49% 13% F 11% F
Trailing 12 Months  
Capital Gain 18.89% 75% C 86% B+
Dividend Return 1.81% 50% F 46% F
Total Return 20.71% 75% C 87% B+
Trailing 5 Years  
Capital Gain 142.99% 88% B+ 89% A-
Dividend Return 26.32% 91% A- 89% A-
Total Return 169.31% 88% B+ 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 22.68% 75% C 80% B-
Dividend Return 27.27% 75% C 84% B
Total Return 4.59% 94% A 87% B+
Risk Return Profile  
Volatility (Standard Deviation) 11.93% 88% B+ 84% B
Risk Adjusted Return 228.53% 100% F 100% F
Market Capitalization 38.11B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Brokers & Exchanges) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.60 54% 35%
Price/Book Ratio 2.70 38% 36%
Price / Cash Flow Ratio 6.30 21% 13%
Price/Free Cash Flow Ratio 26.02 25% 18%
Management Effectiveness  
Return on Equity 19.72% 67% 83%
Return on Invested Capital 9.70% 53% 69%
Return on Assets 6.33% 67% 81%
Debt to Equity Ratio 12.50% 80% 75%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.